Disclosures for "Efficacy of Valbenazine in the Treatment of Cervical Dystonia: A Pilot Study"
-
Dr. Taylor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Taylor has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Taylor has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Taylor has stock in Abbvie. Dr. Taylor has stock in Lilly. Dr. Taylor has stock in NOVO-NORDISK. The institution of Dr. Taylor has received research support from Neurocine Biosciences.
-
Ms. Pellot has nothing to disclose.
-
Miss Abdel-Aziz has nothing to disclose.